MAT1A and liver cancer: The decrease in MAT1A gene expression with a consequent reduction of the MATI and MATIII isoenzymes leads to a marked fall of SAM liver content during acute and chronic liver disease, which predisposes the subject to the development of liver cancer [57,153,154].